The Healthcare Services is pretty flat in the last 7 days, but Sinopharm Group has stood out, gaining 5.6%. As for the longer term, the industry has declined 32% in the last year. Earnings are forecast to grow by 15% annually.
Has the Hong Kong Healthcare Services Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 07 Aug 2024 | HK$228.0b | HK$831.3b | HK$12.7b | 10.9x | 17.9x | 0.3x |
Fri, 05 Jul 2024 | HK$240.7b | HK$818.2b | HK$12.5b | 11x | 19.3x | 0.3x |
Sun, 02 Jun 2024 | HK$253.0b | HK$823.0b | HK$12.5b | 12.6x | 20.2x | 0.3x |
Tue, 30 Apr 2024 | HK$255.2b | HK$821.8b | HK$12.7b | 11.9x | 20x | 0.3x |
Thu, 28 Mar 2024 | HK$238.1b | HK$822.2b | HK$12.8b | 12.2x | 18.7x | 0.3x |
Sat, 24 Feb 2024 | HK$248.9b | HK$815.0b | HK$12.0b | 14.6x | 20.7x | 0.3x |
Mon, 22 Jan 2024 | HK$230.9b | HK$819.5b | HK$12.1b | 15.2x | 19.1x | 0.3x |
Wed, 20 Dec 2023 | HK$235.5b | HK$818.6b | HK$12.4b | 15.4x | 18.9x | 0.3x |
Fri, 17 Nov 2023 | HK$257.3b | HK$805.9b | HK$12.1b | 13.3x | 21.3x | 0.3x |
Sun, 15 Oct 2023 | HK$289.7b | HK$802.6b | HK$12.3b | 13.4x | 23.5x | 0.4x |
Tue, 12 Sep 2023 | HK$284.8b | HK$804.9b | HK$12.7b | 13.1x | 22.4x | 0.4x |
Thu, 10 Aug 2023 | HK$290.4b | HK$782.9b | HK$11.5b | 9.8x | 25.3x | 0.4x |
Sat, 08 Jul 2023 | HK$320.5b | HK$803.3b | -HK$152,178,082.00 | 11.8x | -2105.9x | 0.4x |
Mon, 05 Jun 2023 | HK$316.3b | HK$779.6b | HK$883.5m | 11.3x | 358x | 0.4x |
Wed, 03 May 2023 | HK$336.9b | HK$799.5b | HK$1.3b | 10.8x | 261.2x | 0.4x |
Fri, 31 Mar 2023 | HK$320.9b | HK$798.5b | HK$2.5b | 16.7x | 128x | 0.4x |
Sun, 26 Feb 2023 | HK$311.5b | HK$776.9b | HK$3.3b | 16.2x | 94.1x | 0.4x |
Tue, 24 Jan 2023 | HK$310.6b | HK$793.4b | HK$3.5b | 16.2x | 89.3x | 0.4x |
Thu, 22 Dec 2022 | HK$284.2b | HK$769.0b | HK$3.0b | 14.3x | 95.9x | 0.4x |
Sat, 19 Nov 2022 | HK$265.9b | HK$753.6b | HK$2.2b | 14x | 118.3x | 0.4x |
Mon, 17 Oct 2022 | HK$197.6b | HK$661.1b | -HK$2,214,208,525.00 | 13.1x | -89.2x | 0.3x |
Wed, 14 Sep 2022 | HK$212.4b | HK$684.6b | -HK$2,361,071,723.00 | 16.6x | -90x | 0.3x |
Fri, 12 Aug 2022 | HK$226.8b | HK$694.1b | -HK$6,901,155,986.00 | 17.6x | -32.9x | 0.3x |
Sun, 10 Jul 2022 | HK$242.7b | HK$696.9b | -HK$6,976,338,004.00 | 17.3x | -34.8x | 0.3x |
Tue, 07 Jun 2022 | HK$210.4b | HK$697.8b | -HK$6,169,339,077.00 | 16.9x | -34.1x | 0.3x |
Thu, 05 May 2022 | HK$196.0b | HK$692.4b | -HK$6,928,508,311.00 | 17.4x | -28.3x | 0.3x |
Sat, 02 Apr 2022 | HK$210.5b | HK$732.1b | -HK$4,939,493,897.00 | 16.4x | -42.6x | 0.3x |
Mon, 28 Feb 2022 | HK$254.7b | HK$721.8b | -HK$5,111,493,890.00 | 17.8x | -49.8x | 0.4x |
Wed, 26 Jan 2022 | HK$248.9b | HK$717.9b | -HK$5,298,495,918.00 | 17.6x | -47x | 0.3x |
Fri, 24 Dec 2021 | HK$241.8b | HK$712.3b | -HK$5,430,355,631.00 | 17.5x | -44.5x | 0.3x |
Sun, 21 Nov 2021 | HK$289.1b | HK$709.5b | -HK$5,408,577,447.00 | 17.6x | -53.5x | 0.4x |
Tue, 19 Oct 2021 | HK$328.1b | HK$693.5b | -HK$5,370,864,981.00 | 16.5x | -61.1x | 0.5x |
Thu, 16 Sep 2021 | HK$311.9b | HK$689.6b | -HK$5,408,746,530.02 | 16.8x | -57.7x | 0.5x |
Sat, 14 Aug 2021 | HK$464.7b | HK$689.6b | -HK$5,408,746,530.02 | 16.8x | -85.9x | 0.7x |
-85.9x
Which industries have driven the changes within the Hong Kong Healthcare industry?
HK Market | -2.82% | |
Healthcare | 0.38% | |
Healthcare Services | -0.69% | |
Healthcare Distributors | 0.74% | |
Managed Healthcare | 0% | |
Healthcare Facilities | -1.55% | |
Healthcare Services | -3.32% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
1099 Sinopharm Group | HK$18.84 | 5.6% +HK$3.1b | -12.2% | PE6.1x | |
874 Guangzhou Baiyunshan Pharmaceutical Holdings | HK$20.00 | 3.3% +HK$1.0b | -9.9% | PE7.3x | |
1951 Jinxin Fertility Group | HK$2.61 | 9.2% +HK$604.7m | -36.8% | PE19.1x | |
1515 China Resources Medical Holdings | HK$3.27 | 5.8% +HK$233.4m | -44.8% | PE15.1x | |
9885 YSB | HK$7.86 | 4.8% +HK$230.7m | -85.8% | PS0.3x |